UPDATE 1-Generic drugmaker Mylan trims forecast as FDA approval drags
August 07, 2014 at 09:20 AM EDT
* Cuts top end of FY revenue forecast to $8.0 bln from $8.2 bln
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.